AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
A PHASE-I AND TRANSLATIONAL STUDY OF SEQUENTIAL ADMINISTRATION OF THETOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITORS TOPOTECAN AND ETOPOSIDE
Authors: HAMMOND LA ECKARDT JR GANAPATHI R BURRIS HA RODRIGUEZ GA ECKHARDT SG ROTHENBERG ML WEISS GR KUHN JG HODGES S VONHOFF DD ROWINSKY EK
Citation: La. Hammond et al., A PHASE-I AND TRANSLATIONAL STUDY OF SEQUENTIAL ADMINISTRATION OF THETOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITORS TOPOTECAN AND ETOPOSIDE, Clinical cancer research, 4(6), 1998, pp. 1459-1467
PHASE I II TRIAL OF ALL-TRANS-RETINOIC ACID AND TAMOXIFEN IN PATIENTSWITH ADVANCED BREAST-CANCER/
Authors: BUDD GT ADAMSON PC GUPTA M HOMAYOUN P SANDSTROM SK MURPHY RF MCLAIN D TUASON L PEEREBOOM D BUKOWSKI RM GANAPATHI R
Citation: Gt. Budd et al., PHASE I II TRIAL OF ALL-TRANS-RETINOIC ACID AND TAMOXIFEN IN PATIENTSWITH ADVANCED BREAST-CANCER/, Clinical cancer research, 4(3), 1998, pp. 635-642
PHASE I II TRIAL OF ALL-TRANS-RETINOIC ACID AND TAMOXIFEN IN PATIENTSWITH ADVANCED BREAST-CANCER/
Authors: BUDD GT ADAMSON PC GUPTA M HOMAYOUN P SANDSTROM SK MURPHY RF MCLAIN D TUASON L PEEREBOOM D BUKOWSKI RM GANAPATHI R
Citation: Gt. Budd et al., PHASE I II TRIAL OF ALL-TRANS-RETINOIC ACID AND TAMOXIFEN IN PATIENTSWITH ADVANCED BREAST-CANCER/, Clinical cancer research, 4(3), 1998, pp. 635-642
INTERLEUKIN-6 DIFFERENTIALLY POTENTIATES THE ANTITUMOR EFFECTS OF TAXOL AND VINBLASTINE IN THE HUMAN MYELOMA CELLS, U266
Authors: GANAPATHI MK AOYAMA M GANAPATHI R BUKOWSKI RM MACLSAAC D
Citation: Mk. Ganapathi et al., INTERLEUKIN-6 DIFFERENTIALLY POTENTIATES THE ANTITUMOR EFFECTS OF TAXOL AND VINBLASTINE IN THE HUMAN MYELOMA CELLS, U266, Annals of oncology, 9, 1998, pp. 314-314
CLINICAL PHARMACOKINETICS OF PERILLYL ALCOHOL (POH) AND METABOLITES FOLLOWING ORAL DOSING
Authors: CHAN KK ZHANG Z CHEN H GANAPATHI R HAYTON W ELSON P HAWK E KELLOFF G BUDD GT
Citation: Kk. Chan et al., CLINICAL PHARMACOKINETICS OF PERILLYL ALCOHOL (POH) AND METABOLITES FOLLOWING ORAL DOSING, Annals of oncology, 9, 1998, pp. 476-476
DRUG-RESISTANCE IN HUMAN NONSMALL CELL LUNG-CARCINOMA - RELEVANCE OF MULTIDRUG-RESISTANT GENE-EXPRESSION AND SENSITIVITY TO TOPOISOMERASE OR MICROTUBULE POISONS
Authors: GANAPATHI R KIM S GRABOWSKI D AOYAMA M RICE T BUKOWSKI R GANAPATHI M
Citation: R. Ganapathi et al., DRUG-RESISTANCE IN HUMAN NONSMALL CELL LUNG-CARCINOMA - RELEVANCE OF MULTIDRUG-RESISTANT GENE-EXPRESSION AND SENSITIVITY TO TOPOISOMERASE OR MICROTUBULE POISONS, Annals of oncology, 9, 1998, pp. 577-577
EFFECT OF SULINDAC SULFONE ON PROLIFERATION, APOPTOSIS, AND POLYPS INA CLINICAL-TRIAL IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) WITH RECTAL POLYPS
Authors: VANSTOLK R BUDD GT KRESTY R GANAPATHI R ELSON P CHURCH J PIAZZA G FRYER B PROVENCHER K PAMUKCU R HAWK E KELLOFF G STONER G
Citation: R. Vanstolk et al., EFFECT OF SULINDAC SULFONE ON PROLIFERATION, APOPTOSIS, AND POLYPS INA CLINICAL-TRIAL IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) WITH RECTAL POLYPS, Gastroenterology, 114(4), 1998, pp. 2881-2881
ALTERED EXPRESSION AND ACTIVITY OF TOPOISOMERASES DURING ALL-TRANS-RETINOIC ACID-INDUCED DIFFERENTIATION OF HL-60 CELLS
Authors: AOYAMA M GRABOWSKI DR ISAACS RJ KRIVACIC KA RYBICKI LA BUKOWSKI RM GANAPATHI MK HICKSON ID GANAPATHI R
Citation: M. Aoyama et al., ALTERED EXPRESSION AND ACTIVITY OF TOPOISOMERASES DURING ALL-TRANS-RETINOIC ACID-INDUCED DIFFERENTIATION OF HL-60 CELLS, Blood, 92(8), 1998, pp. 2863-2870
TUMOR-CELL RESISTANCE TO TOPOISOMERASE-II POISONS - ROLE FOR INTRACELLULAR FREE CALCIUM IN THE SENSITIZATION BY INHIBITORS OF CALCIUM-CALMODULIN-DEPENDENT ENZYMES
Authors: GRABOWSKI DR DUBYAK GR RYBICKI L HIDAKA H GANAPATHI R
Citation: Dr. Grabowski et al., TUMOR-CELL RESISTANCE TO TOPOISOMERASE-II POISONS - ROLE FOR INTRACELLULAR FREE CALCIUM IN THE SENSITIZATION BY INHIBITORS OF CALCIUM-CALMODULIN-DEPENDENT ENZYMES, Biochemical pharmacology, 56(3), 1998, pp. 345-349
SELECTIVE APOPTOSIS OF NEOPLASTIC-CELLS ACCOMPANIES POLYP REGRESSION IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) PATIENTS TREATED WITH FGN-1 (SULINDAC SULFONE) - EVIDENCE FOR A CYCLOOXYGENASE INDEPENDENT MECHANISM
Authors: PIAZZA GA FRYER BH VANSTOLK RU BUDD GT STONER GD HAWK E KELLOFF G PAMUKCU R AHNEN DJ GANAPATHI R
Citation: Ga. Piazza et al., SELECTIVE APOPTOSIS OF NEOPLASTIC-CELLS ACCOMPANIES POLYP REGRESSION IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) PATIENTS TREATED WITH FGN-1 (SULINDAC SULFONE) - EVIDENCE FOR A CYCLOOXYGENASE INDEPENDENT MECHANISM, Gastroenterology, 112(4), 1997, pp. 638-638
PHASE-I TRIAL OF SULINDAC SULFONE IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP) WITH RECTAL POLYPS - OPTIMAL DOSE AND SAFETY
Authors: VANSTOLK RU BUDD GT HAYTON W ELSON P PROVENCHER K CHURCH JM GANAPATHI R STONER G HAWK E PAMUKCU R KELLOFF G CHAN K
Citation: Ru. Vanstolk et al., PHASE-I TRIAL OF SULINDAC SULFONE IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP) WITH RECTAL POLYPS - OPTIMAL DOSE AND SAFETY, Gastroenterology, 112(4), 1997, pp. 673-673
CLINICOPATHOLOGICAL CORRELATION OF RECTAL ADENOMA REGRESSION IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP) TREATED WITH SULINDAC SULFONE IN A PHASE I II TRIAL/
Authors: VANSTOLK RU DEYOUNG B CHURCH JM GANAPATHI R PROVENCHER K STONER G HAWK E PAMUKCU R KELLOFF G BUDD GT
Citation: Ru. Vanstolk et al., CLINICOPATHOLOGICAL CORRELATION OF RECTAL ADENOMA REGRESSION IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP) TREATED WITH SULINDAC SULFONE IN A PHASE I II TRIAL/, Gastroenterology, 112(4), 1997, pp. 673-673
RANDOMIZED TRIAL OF CARBOPLATIN PLUS AMIFOSTINE VERSUS CARBOPLATIN ALONE IN PATIENTS WITH ADVANCED SOLID TUMORS
Authors: BUDD GT GANAPATHI R ADELSTEIN DJ PELLEY R OLENCKI T PETRUS J MCLAIN D ZHANG JL CAPIZZI R BUKOWSKI RM
Citation: Gt. Budd et al., RANDOMIZED TRIAL OF CARBOPLATIN PLUS AMIFOSTINE VERSUS CARBOPLATIN ALONE IN PATIENTS WITH ADVANCED SOLID TUMORS, Cancer, 80(6), 1997, pp. 1134-1140
RESISTANCE TO INTERLEUKIN-6 IN HUMAN NONSMALL CELL LUNG-CARCINOMA CELL-LINES - ROLE OF RECEPTOR COMPONENTS
Authors: GANAPATHI MK WEIZER AK BORSELLINO S BUKOWSKI RM GANAPATHI R RICE T CASEY G KAWAMURA K
Citation: Mk. Ganapathi et al., RESISTANCE TO INTERLEUKIN-6 IN HUMAN NONSMALL CELL LUNG-CARCINOMA CELL-LINES - ROLE OF RECEPTOR COMPONENTS, Cell growth & differentiation, 7(7), 1996, pp. 923-929
CLINICAL EFFECTS OF AMIFOSTINE (ETHYOL(R)) IN PATIENTS TREATED WITH CARBOPLATIN
Authors: BUDD GT GANAPATHI R BUKOWSKI RM MURTHY S
Citation: Gt. Budd et al., CLINICAL EFFECTS OF AMIFOSTINE (ETHYOL(R)) IN PATIENTS TREATED WITH CARBOPLATIN, European journal of cancer, 32A, 1996, pp. 43-45
ACQUISITION OF DOXORUBICIN RESISTANCE IN HUMAN LEUKEMIA HL-60 CELLS IS REPRODUCIBLY ASSOCIATED WITH 7Q21 CHROMOSOMAL-ANOMALIES
Authors: GANAPATHI R HOELTGE G CASEY G GRABOWSKI D NEELON R FORD J
Citation: R. Ganapathi et al., ACQUISITION OF DOXORUBICIN RESISTANCE IN HUMAN LEUKEMIA HL-60 CELLS IS REPRODUCIBLY ASSOCIATED WITH 7Q21 CHROMOSOMAL-ANOMALIES, Cancer genetics and cytogenetics, 86(2), 1996, pp. 116-119
RESISTANCE TO ETOPOSIDE IN HUMAN LEUKEMIA HL-60 CELLS - REDUCTION IN DRUG-INDUCED DNA CLEAVAGE ASSOCIATED WITH HYPOPHOSPHORYLATION OF TOPOISOMERASE-II PHOSPHOPEPTIDES
Authors: GANAPATHI R CONSTANTINOU A KAMATH N DUBYAK G GRABOWSKI D KRIVACIC K
Citation: R. Ganapathi et al., RESISTANCE TO ETOPOSIDE IN HUMAN LEUKEMIA HL-60 CELLS - REDUCTION IN DRUG-INDUCED DNA CLEAVAGE ASSOCIATED WITH HYPOPHOSPHORYLATION OF TOPOISOMERASE-II PHOSPHOPEPTIDES, Molecular pharmacology, 50(2), 1996, pp. 243-248
MODULATION OF VINBLASTINE CYTOTOXICITY BY DILANTIN (PHENYTOIN) OR THEPROTEIN PHOSPHATASE INHIBITOR OKADAIC ACID INVOLVES THE POTENTIATION OF ANTI-MITOTIC EFFECTS AND INDUCTION OF APOPTOSIS IN HUMAN TUMOR-CELLS
Authors: KAWAMURA KI GRABOWSKI D WEIZER K BUKOWSKI R GANAPATHI R
Citation: Ki. Kawamura et al., MODULATION OF VINBLASTINE CYTOTOXICITY BY DILANTIN (PHENYTOIN) OR THEPROTEIN PHOSPHATASE INHIBITOR OKADAIC ACID INVOLVES THE POTENTIATION OF ANTI-MITOTIC EFFECTS AND INDUCTION OF APOPTOSIS IN HUMAN TUMOR-CELLS, British Journal of Cancer, 73(2), 1996, pp. 183-188
CELLULAR EVENTS INVOLVED IN THE SENSITIZATION OF ETOPOSIDE RESISTANT CELLS BY INHIBITORS OF CALCIUM-CALMODULIN-DEPENDENT PROCESSES - ROLE FOR EFFECTS ON APOPTOSIS, DNA CLEAVABLE COMPLEX, AND PHOSPHORYLATION
Authors: KAWAMURA KI GRABOWSKI D KRIVACIC K HIDAKA H GANAPATHI R
Citation: Ki. Kawamura et al., CELLULAR EVENTS INVOLVED IN THE SENSITIZATION OF ETOPOSIDE RESISTANT CELLS BY INHIBITORS OF CALCIUM-CALMODULIN-DEPENDENT PROCESSES - ROLE FOR EFFECTS ON APOPTOSIS, DNA CLEAVABLE COMPLEX, AND PHOSPHORYLATION, Biochemical pharmacology, 52(12), 1996, pp. 1903-1909
DRASTIC REDUCTION OF TOPOISOMERASE II-ALPHA ASSOCIATED WITH MAJOR ACQUIRED-RESISTANCE TO TOPOISOMERASE-II ACTIVE AGENTS BUT MINOR PERTURBATIONS OF CELL-GROWTH
Authors: HASHIMOTO S CHATTERJEE S RANJIT GB BAO CY FORD J GANAPATHI R BERGER SJ BERGER NA
Citation: S. Hashimoto et al., DRASTIC REDUCTION OF TOPOISOMERASE II-ALPHA ASSOCIATED WITH MAJOR ACQUIRED-RESISTANCE TO TOPOISOMERASE-II ACTIVE AGENTS BUT MINOR PERTURBATIONS OF CELL-GROWTH, Oncology research, 7(7-8), 1995, pp. 407-416
DRASTIC REDUCTION OF TOPOISMERASE II-ALPHA ASSOCIATED WITH MAJOR ACQUIRED-RESISTANCE TO TOPOISOMERASE-II ACTIVE AGENTS BUT MINOR PERTURBATIONS OF CELL-GROWTH (VOL 7, PG 407, 1995)
Authors: HASHIMOTO S CHATTERJEE S RANJIT GB BAO CY FORD J GANAPATHI R BERGER SJ BERGER NA
Citation: S. Hashimoto et al., DRASTIC REDUCTION OF TOPOISMERASE II-ALPHA ASSOCIATED WITH MAJOR ACQUIRED-RESISTANCE TO TOPOISOMERASE-II ACTIVE AGENTS BUT MINOR PERTURBATIONS OF CELL-GROWTH (VOL 7, PG 407, 1995), Oncology research, 7(10-11), 1995, pp. 565-565
DIFFERENTIAL EXPRESSION AND PHOSPHORYLATION OF TOPOISOMERASE-II ISOFORMS ALPHA (170 KDA) AND BETA (180 KDA) DURING RETINOIC ACID-INDUCED DIFFERENTIATION OF HUMAN LEUKEMIA HL-60 CELLS
Authors: GANAPATHI R KRIVACIC K GRABOWSKI D BUKOWSKI R
Citation: R. Ganapathi et al., DIFFERENTIAL EXPRESSION AND PHOSPHORYLATION OF TOPOISOMERASE-II ISOFORMS ALPHA (170 KDA) AND BETA (180 KDA) DURING RETINOIC ACID-INDUCED DIFFERENTIATION OF HUMAN LEUKEMIA HL-60 CELLS, Blood, 86(10), 1995, pp. 2643-2643
PHASE-I TRIAL OF CISPLATIN, WR-2721, AND THE MURINE MONOCLONAL-ANTIBODY R24 IN PATIENTS WITH METASTATIC MELANOMA - CLINICAL AND BIOLOGIC EFFECTS
Authors: BUKOWSKI RM MURTHY SA FINKE J CAULFIELD MJ TUBBS R HERZOG P STANLEY J EDINGER M TUASON L MCLAIN D BUDD GT OLENCKI T GANAPATHI R
Citation: Rm. Bukowski et al., PHASE-I TRIAL OF CISPLATIN, WR-2721, AND THE MURINE MONOCLONAL-ANTIBODY R24 IN PATIENTS WITH METASTATIC MELANOMA - CLINICAL AND BIOLOGIC EFFECTS, Journal of immunotherapy with emphasis on tumor immunology, 15(4), 1994, pp. 273-282
AMIFOSTINE - POTENTIAL FOR CLINICALLY USEFUL CYTOPROTECTION
Authors: BUDD GT LORENZI V GANAPATHI R ADELSTEIN D PELLEY R OLENCKI T MCLAIN D BUKOWSKI RM
Citation: Gt. Budd et al., AMIFOSTINE - POTENTIAL FOR CLINICALLY USEFUL CYTOPROTECTION, Supportive care in cancer, 2(6), 1994, pp. 380-384
MECHANISMS INVOLVED IN THE SELECTIVE ENHANCEMENT OF VINCA-ALKALOID CYTOTOXICITY BY THE ANTIEPILEPTIC PHENYTOIN
Authors: GANAPATHI R GRABOWSKI D WEIZER K FORD J RICE T BUKOWSKI R
Citation: R. Ganapathi et al., MECHANISMS INVOLVED IN THE SELECTIVE ENHANCEMENT OF VINCA-ALKALOID CYTOTOXICITY BY THE ANTIEPILEPTIC PHENYTOIN, Journal of cellular biochemistry, 1994, pp. 106-106
Risultati: 1-25 | 26-32